Background. Older age has been associated with impaired CD4 recovery and a low CD4:CD8 ratio is an independent predictor of non-AIDS morbidity/mortality. In this study we describe the overall comorbidity burden and assess factors associated with CD4:CD8 <1 among HIV+ older adults 60 years+ seen at CORE Center, Cook County Health and Hospital System; a safety-net health system.
Background. Compared with the general population, PLWH have higher rates of tobacco use. We performed a prospective single-arm pilot study of the real-world feasibility of integrating an ambulatory smoking cessation decisional algorithm in our HIV clinic. We hypothesized that patients with drug and alcohol abuse would have a smaller change in smoking related behaviors.
Methods. Participants were PLWH attending our clinic and smoking at least 5 cigarettes/day regardless of their motivation to quit (N = 60). Each participant had an initial visit and two phone visits (+1 and +3 months). Participants completed surveys via computer during the first visit and by phone in the follow-ups. Additional clinical data were collected via chart review.
Results. Participants had a mean age of 48, were mostly African-American (72%) and male (67%) with well-controlled HIV (mean CD4 622, undetectable viral load in 70%). The mean AUDIT score to assess for alcohol abuse did not change over the. three time points (7.1;7.2;7.6, median 4;5;5). A score of 8 or higher indicates harmful alcohol consumption and 23% of patients met the criteria. Lifetime self-reported treatment for substance abuse was high (35%). DAST score for assessing substance abuse was used and mean scores decreased slightly over time (2.3;1.2;0.93, median 2;0;0). A score of 6 or higher indicates a substance use disorder and 15% met that criterion at baseline, 3% at 3 months. Chart review had similar results with 18% having a diagnosis of substance abuse and 20% with alcohol abuse. Overall participants (n = 60) showed a decrease in tobacco use, with an average of 14 cigarettes/day at baseline and 7 cigarettes/day at 3 months (P = 0.001). Patients with a diagnosis of substance abuse had a baseline average of 12 cigarettes/day and 6 cigarettes/day at 3 months (reduction 6). For those with an alcohol abuse diagnosis, baseline was 16 cigarettes/day and at 3 months, 10 cigarettes/day (reduction 6). The change over time was not significantly different between the groups.
Conclusion. People living with HIV who smoke are a complex group of patients who commonly have concurrent or historical substance and alcohol abuse. A substance and alcohol abuse diagnosis did not impact the decrease in tobacco use seen with implementation of a decisional algorithm.
Disclosures. All authors: No reported disclosures. Methods. A cross-sectional analysis of ADHOC was performed on 208 PLHIV 50+ years of age. One hypothesis was that increasing age would be associated with greater loneliness. Loneliness was assessed using the UCLA Loneliness Scale (ULS-3). A score ≥6 was classified as lonely. The impact of aging on loneliness was analyzed by ANOVA and multiple linear regression.
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Results. ULS-3 scores ranged from 3 to 9 and 48.6% of subjects were classified as lonely. Significant differences were found between the 50-59, 60-65 and 65+ age groups, with older age associated with decreased loneliness (P = 0.018) ( Table 1 ). In the multiple linear regression model, these observations persisted even after controlling for gender, sexual orientation, race/ethnicity, relationship status, education, income, and number of comorbidities (Table 2 ). Decreases in loneliness were associated with female gender, being in a relationship, higher income, and fewer comorbidities (P < 0.05).
Conclusion. Among PLHIV over 50, loneliness is less severe in older age groups. Additional investigation is needed to better understand potential causes and to find ways to remediate loneliness among older PLHIV. October 4, 2018: 12:30 PM Background. Congenital infections cause significant morbidity globally. In the United States, population studies have indicated that congenital infections disproportionately affect minorities and the economically disadvantaged. Through their chronic and disabling effects these infections perpetuate generational poverty among these groups. The objectives of this study were to (i) provide a national prevalence estimate of congenital infections in children 0-2 years using discharge diagnosis codes; (ii) compare risk of congenital infection between white and non-White children; and (iii) investigate the relationship between socioeconomic status and risk of congenital infection in the United States.
Methods. The 2012 HCUP Kids' Inpatient Database was used to identify discharges of children 0-2 years with an ICD-9 diagnosis code for congenital CMV (771.1), congenital syphilis (090.0-9), or congenital infection other (771.2). Univariate and multivariate logistic regression was used to estimate prevalence rates and potential risk factors for these infections.
Results. Prevalence of any congenital infection in children ages 0-2 years is .048%. Risk factor analyses found that African-American children are 1 Conclusion. Risk for congenital infections in children 0-2 years in the United States is substantially higher for non-Whites, those with Medicaid insurance, and those in lower income households supporting previous literature suggesting that these infections disproportionately affect socially and economically disadvantaged groups. Further research is needed to define optimal cost-effective screening and prevention strategies.
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